Evaluation of some adamantane-based synthetic trioxanes against Plasmodium knowlesi in rhesus monkeys

Life Sciences

Volumn 81, Issue 21-22, 2007, Pages 1544-1548

  Tripathi, Renu ^a   Mishra, Dhermendra ^a   Rizvi, Amber ^a   Singh, Chandan ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antimalarials; Malaria; Plasmodium knowlesi; Trioxanes

Indexed keywords

1,2,4 TRIOXANE DERIVATIVE; ADAMANTANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALARIA; NONHUMAN; PARASITE; PLASMODIUM KNOWLESI; RHESUS MONKEY; SWISS WEBSTER MOUSE;

ADAMANTANE; ANIMALS; ANTIMALARIALS; ERYTHROCYTES; INJECTIONS, INTRAMUSCULAR; MACACA MULATTA; MALARIA; PLASMODIUM KNOWLESI; RECURRENCE;

MACACA MULATTA; MUS; PLASMODIUM KNOWLESI;

EID: 35848951630     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.09.023     Document Type: Article

References (50)

1. Anon. China Cooperative Research Group on qinghaosu and its derivative antimalarials: the chemistry and synthesis of qinghaosu derivatives. Journal of Traditional Chinese Medicine 2 (1982) 9-16
2. Anon. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials: antimalarial efficacy and mode of action of qinghaosu and its derivatives in experimental models. Journal of Traditional Chinese Medicine 2 (1982) 17-24
3. Anon. The artemether-quinine meta-analysis study group: a meta-analysis using individual patient data of trials comprising artemether with quinine in the treatment of severe falciparum malaria. Transaction of Royal Society of Tropical Medicine and Hygiene 95 (2001) 637-650
4. Awad M.I., Alkadru A.M., Behrens R.H., Baraka O.Z., and Eltayeb I.B. Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan. American Journal of Tropical Medicine and Hygiene 68 2 (2003) 153-158
5. Bajpai R., Dutta G.P., and Vishwakarma R.A. Schizontocidal activity of a new antimalarial drug arteether against Plasmodium knowlesi in rhesus monkey. Transaction of Royal Society of Tropical Medicine and Hygiene 83 (1989) 484
6. Bjorkman A., and Phillips-Howard P.A. Drug resistant malaria: mechanism of development and inferences for malaria control. Transaction of Royal Society of Tropical Medicine and Hygiene 84 3 (1990) 323-324
7. Brossi A., Venugopalan B., Gerpe L.D., Yeh H.J.C., Flippen-Anderson J.L., Buchs P., Luo X.D., Milhous W., and Peters W. Arteether, a new antimalarial drug: synthesis and antimalarial properties. Journal of Medicinal Chemistry 31 (1988) 645-650
8. Cumming J.N., Polypradith P., and Posner G.H. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes mechanism(s) of action. Advances in Pharmacology 37 (1997) 254-297
9. Dutta G.P., and Tripathi R. Arteether α/β - a fast acting antimalarial. Japanese Journal of Tropical Medicine and Hygiene 24 (1996) 65-69
10. Dutta G.P., and Tripathi R. New antimalarial drug development in India: arteether α/β - a blood schizontocide. Proceedings of Indian National Science Academy B69 vol. 6 (2003) 861-870
11. Dutta G.P., Bajpai R., and Vishwakarma R.A. Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis. Pharmacological Research 21 (1989) 415-419
12. Fleck S.L., Robinson B.L., Peters W., Thevin F., Boulard Y., Glenat C., Caillard V., and Landu I. The chemotherapy of rodent malaria. LIII Fenozan B07 (Fenozan-50F), a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series. Annals of Tropical Medicine and Parasitology 91 (1997) 25-32
13. Fleck S.L., Robinson B.L., and Peters W. The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug resistant parasites. Annals of Tropical Medicine and Parasitology 91 (1997) 33-39
14. Goldsmith R.S. Antiprotozoal drugs. In: Katzung B.G. (Ed). Basic and Clinical Pharmacology (1992), Appleton & Lange, Norwalk, CT chapter 54
15. Jefford C.W., Megoran E.C., and Boukouvalas J. Synthesis of new 1,2,4-trioxanes and their antimalarial activity. Helvetica Chimica Acta 71 (1988) 1805-1812
16. Jefford C.W., Velarde J.A., and Bernardelli G. Synthesis, structure and antimalarial activity of Tricyclic 1,2,4-trioxanes related to artemisinin. Helvetica Chimica Acta 76 (1993) 2775-2778
17. Jefford W., Shigeo Kohmoto S., and Jaggi D. Synthesis, structure and antimalarial activity of some enantiomerically pure, cis-fused cyclopenteno 1,2,4-trioxanes. Helvetica Chimica Acta 78 (1995) 647-662
18. Lin A.J., Klayman D.L., and Milhous W.K. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. Journal of Medicinal Chemistry 30 11 (1987) 2147-2150
19. Looareesuwan S., Viravan C., Vanijanonta S., Kyle D., and Webster K. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339 (1992) 821-824
20. Maeno Y., Brown A.E., Smith C.D., Tegoshi T., Toyoshima T., Ockenhouse C.F., Corcoran K.D., Nganpochjana M., Kyle D.E., Webster H.K., and Aikawa M. A non human primate model for human cerebral malaria: effects of artesunate (Qinghaosu derivative) on rhesus monkeys experimentally infected with Plasmodium Coatneyi. American Journal of Tropical Medicine and Hygiene 49 6 (1993) 726-734
21. Meshnick S.R., Jefford C.W., Posner G.H., Avery M.A., and Peter W. Second-generation antimalarial endoperoxides. Parasitology Today 12 (1996) 79-82
22. Nguyen M.H., Davis T.M., Cox-Singh J., Hewitt S., Tran Q.T., Tran B.K., Nguyen T.H., Vo N.P., Doan H.N., and Le D.C. Treatment of uncomplicated falciparum malaria in southern Vietnam: can chloroquine or sulfadoxine-pyrimethamine be reintroduced in combination with artesunate?. Clinical Infectious Diseases 37 11 (2003) 1461-1466
23. Nosten F., Terkulie F., Chongsuphajaisiddhi T., White N.J., Kuile F.T., Luxem Burger C., Webster, H.K., Edstein M., Phaipan L., Thew K.L., and White N.J. Mefloquine resistant P. falciparum malaria on the Thai Burmese border. Lancet 337 (1991) 1140-1143
24. Olliaro P., Cattani J., and Wirth D. Malaria, the submerged disease. Journal of American Medical Association 275 (1996) 230-233
25. Park B.K., O'Neill P.M., Maggs J.L., and Pirmohamed M. Safety assessment of peroxide antimalarials: clinical and chemical perspectives. British Journal of Clinical Pharmacology 46 (1998) 521-529
26. Peters W., Robinson B.L., Rossier J.C., and Jefford C.W. The chemotherapy of rodent malaria XLVIII. The activities of some synthetic 1,2,4-trioxanes against chloroquine sensitive and chloroquine resistant parasites. Part-I studies leading to the development of novel cis-fused cyclopenteno derivatives. Annals of Tropical Medicine and Parasitology 87 (1993) 1-7
27. Peters W., Robinson B.L., Rossier J.C., and Jefford C.W. The chemotherapy of rodent malaria XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine sensitive and chloroquine resistant parasites. Part 2. Structure activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug sensitive and drug resistant lines of Plasmodium berghei and P. yoelii spp. NS in vivo. Annals of Tropical Medicine and Parasitology 87 (1993) 9-16
28. Peters W., Robinson B.L., Tovey G., Rossier J.C., and Jefford C.W. The chemotherapy of rodent malaria. The activities of some synthetic 1,2,4-trioxanes against chloroquine sensitive and chloroquine resistant parasites. Part 3, observation on 'Fenozan 50F' a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane. Annals of Tropical Medicine and Parasitology 87 2 (1993) 111-123
29. Posner G.H., and Oh C.H. A oxygen 18 labeled 1,2,4-trioxanes. Journal of American Chemical Society 114 (1992) 8328-8329
30. Posner G.H., Oh C.H., Webster H.K., Ager Jr. A.L., and Rossan R.N. New antimalarial tricyclic 1, 2, 4-trioxanes evaluations in mice and monkey. American Journal of Tropical Medicine and Hygiene 50 (1994) 522-526
31. Posner G.H., Wang D., Cumming J.N., Oh C.H., French A.N., Bodley A.L., and Shapiro T.A. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1, 2, 4-trioxanes like artemisinin. Journal of Medicinal Chemistry 38 13 (1995) 2273-2275
32. Posner G.H., Paik I.-H., Chang W., Borstrick K., Sinishtaj S., Rosenthal A.S., and Shapiro T.A. Malaria-infected mice are cured by a single dose of novel artemisinin derivatives. Journal of Medicinal Chemistry 50 10 (2007) 2516-2519
33. Pukrittayamee S., Supanaranond W., Looreesuwan S., Vanjianonta S., and White N.J. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Transaction of Royal Society of Tropical Medical and Hygiene 88 (1994) 324-327
34. Radloff P.D., Phillips J., Nkeyi M., Sturchler D., Mittebh M.L., and Kremsner P.G. Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children. American Journal of Tropical Medicine and Hygiene 55 (1996) 259-262
35. Remme J.H., Blas E., Chitsulo L., Desjeux P.M., Engers H.D., Kanyok T.P., Kengeya Kayondo J.F., Kioy D.W., Kumaraswami V., Lazdins J.K., Nunn P.P., Oduola A., Ridley R.G., Toure Y.T., Zicker F., and Morel C.M. Strategic emphases for tropical diseases research: a TDR prospective. Trends in Parasitology 18 (2002) 421-426
36. Seaton R.A., Trevett A.J., Wembri J.P., Nwokolo N., Naraqi S., Black J., Laurenson I.F., Kevau I., Saweri A., Lalloo D.G., and Warrell D.A. Randomized comparison of intramuscular artemether and intravenous quinine in adult, Melanesian patients with severe or complicated Plasmodium falciparum malaria in Papua Guinea. Annals of Tropical Medicine and Parasitology 92 2 (1998) 133-139
37. Singh P.P., and Dutta G.P. Antimalarial activity of mefloquine and chloroquine against blood induced Plasmodium knowlesi infection in rhesus monkeys. Indian Journal of Medical Research 73 (1981) 23-28 (Suppl.)
38. Singh, C., Puri, S.K. 2001. U.S. Patent.6316493. Substituted 1, 2, 4 trioxanes as antimalarial agents and a process of producing the substituted 1,2,4 trioxanes.
39. Singh C., Misra D., Saxena G., and Chandra S. Synthesis of in vivo potent antimalarial 1,2,4-trioxanes. Bioorganic & Medicinal Chemistry Letters 2 5 (1992) 497-500
40. Tang Y., Dong Y., and Vennerstrom J.L. Synthetic peroxide as antimalarials. Molecular Research Review 24 (2004) 425-448
41. TDR News, 2000. Dutch registration for artemotil injections 63, 13.
42. Tripathi R., Jefford C.W., and Dutta G.P. Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans)against multidrug resistant strain of Plasmodium yeolii nigeriensis (MDR) in vivo. Parasitology 133 (2006) 1-9
43. van Agtmael M.A., Gupta V., van der Graaf C.A., and van Boxtel C.J. The effect of grapefruit juice on the time- dependent decline of artemether plasma levels in healthy subjects. Clinical Pharmacology and Therapeutics 66 4 (1999) 408-414
44. van Vugt M., Brockman A., Gemperli B., Luxemberger C., Gathmann I., Royce C., Slight T., Looareesuwan S., White N.J., and Nosten F. Randomised comparison of artemether- benflumetol and artesunate-mefloquine in treatment of multidrug- resistant falciparum malaria. Antimicrobial Agents and Chemotherapy 42 1 (1998) 135-139
45. van Vugt M., Looareesuwan S., Wilairatana P., Mc Gready R., Villegas L., Gathmann I., Mull R., Brockman A., White N.J., and Nosten F. Artemether- Lumifantrine for the treatment of multi-drug resistant falciparum malaria. Transactions of Royal Society of Tropical Medicine and Hygiene 94 5 (2000) 545-548
46. Vennerstrom J.L., Barnes S.A., Brun R., Charman S.A., Chlu F.C.K., Chollet J., Dong Y., Dorn A., Hunziker D., Matile H., Mcintosh K., Padmanilayam M., Tomas J.S., Scheurer C., Scorneaux B., Tang Y., Scheurer C., Urwyler H., Wittilin S., and Charman W.N. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430 (2004) 900-904
47. Wernsdorfer W.H. The development and spread of drug resistant malaria. Parasitology Today 7 11 (1991) 297-303
48. White N.J. Clinical; pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Transaction of Royal Society of Tropical Medicine and Hygiene 88 Suppl-1 (1994) 41-43
49. WHO News. Malaria kills 3000 children a day in Africa. Bulletin of World Health Organization 81 (2003) 472
50. Zaman S.S., and Sgarnam P.P. Some aspects of the chemistry and biological activity of artemisinin and related antimalarials. Heterocycles 32 (1991) 1593-1638